F 0554
Allow residents to self-administer drugs if determined clinically appropriate.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to conduct medication self-administration
assessment to ensure safety for 3 of 3 residents reviewed for self-administration of medications, of a total
sample of 41 residents, (#8, #86 & #113).1.Resident #8 was initially admitted to the facility on [DATE] and
readmitted on [DATE] with diagnoses that included cerebral palsy, acute kidney failure, unspecified
glaucoma, type 2 diabetes mellitus, blindness to the left eye and dysphagia.
Residents Affected - Few
A review of the Minimum Data Set (MDS) admission Five-day assessment with assessment reference date
(ARD) of 6/19/25 revealed resident # 8 had a Brief Interview for Mental Status (BIMS) Score of 14 out of 15
which indicated she was cognitively intact. The MDS assessment revealed the resident had no behaviors,
nor rejection of care and her vision was highly impaired.
A review of resident #8's electronic medical record revealed no physician's order to self-administer
medications, no care plan for self-administration of medications, nor an assessment completed to indicate it
was safe for resident #8 to self-administer her medications.
A review of the Medication Administration Audit report for 9/22/25 revealed documentation that Licensed
Practical Nurse (LPN) A administered the Omega 3 Oral Capsule 1000 milligrams (mg) at 10:57 AM, along
with all of resident #8's other morning medications between 10:56 AM and 10:59 AM.
On 9/22/25 at 12:05 PM resident #8 was in her room with a friend standing at her bedside. There was a
large, clear yellowish capsule in a medication cup with some applesauce in another medication cup on the
resident's bedside table. The resident stated the medication was fish oil and that because this was such a
large pill, she took a long time to swallow it. Resident #8 said she had asked the nurse to leave the pills
because she understood the nurses were quite busy and did not want her to be held up. She explained her
friend would assist her with the medications. The resident's friend said it was okay; she would help
administer the pills. The friend continued to explain that resident #8 took the small pills with no problem, but
the fish oil took a while to swallow, which was why it was still there on the bedside table.
On 9/22/25 at 3:48 PM, LPN A explained for resident #8 that today was the only time she did that [left the
medication at the bedside] because she was called away by the Unit Manager (UM). The nurse confirmed
that even though she was called away, she should not have allowed resident #8's friend to help administer
the medication. The UM for the 300 and 400 halls joined the interview and LPN A explained that because
the UM called her away, she left the medication with the resident's friend. The UM confirmed the resident
did not have a self-administration assessment completed nor was she care planned to allow her friend to
assist with self-administration of medications. The UM continued to explain that the assigned nurse, LPN A,
should have not allowed the resident's friend to administer
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
105291
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105291
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/25/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Life Care Center of Melbourne
606 E Sheridan Rd
Melbourne, FL 32901
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0554
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
medications even if she was called away. She said LPN A should have taken the medication with her or
else remained and completed the administration herself.
On 9/22/2025 at 4:40 PM, the Nursing Home Administrator (NHA) and the Director of Nursing (DON)
acknowledged the situation, stated it was not their normal standard of practice to leave medications at
bedside and acknowledged it should not have happened.
2. Resident #86 was admitted to the facility on [DATE] with diagnoses that included hemiplegia and
hemiparesis following cerebral infarction affecting the left dominant side, generalized weakness, insomnia
and depression.
A review of the MDS Quarterly assessment with ARD of 6/28/25 revealed resident # 86 had a BIMS Score
of 14 out of 15 which indicated she was cognitively intact. The MDS assessment revealed the resident had
no behaviors, nor rejection of care.
A review of resident #86's Plan of Care revealed the resident had actual impairment to skin integrity related
to seborrheic dermatitis of the face and head which was initiated on 3/07/25 and included interventions that
read Treatment as ordered.
On 9/22/25 at 11:48 AM, resident # 86 was in bed, alert and oriented. There was a tube of Hydrocortisone
cream without a cap on her bedside table, and she stated that she used it a while ago for a rash on her
face. The resident continued to explain she applied the cream to her face twice a day but stopped using it
after she had lost the cap.
On 9/22/25 at 3:55 PM, LPN A verified the hydrocortisone cream at resident #86's bedside. LPN A said she
did not know about the Hydrocortisone cream for resident # 86 at the bedside. The UM walked into resident
#86's room and verified the Hydrocortisone cream. The resident stated to the assigned nurse and the UM
that the cream was given to her by the Dermatologist a while back and she used it for the rash on her face.
A short time later the UM confirmed in the electronic medical record no self-administration assessment had
been completed for resident #86 and said they did not even know resident #86 had an order for
Hydrocortisone cream. The UM explained it was probably an old order since there were no current orders
for Hydrocortisone cream. She then found an order dated March 2025 from a Dermatologist note. The UM
said that resident #86 should have an order to self-administer medications and should have had an
assessment completed in order to do so.
On 9/22/25 at 4:40 PM, the DON and NHA said it was not the facility's standard of practice to have
medications at the bedside unless the resident had an order to self-administer medications. The NHA
confirmed the nurse required education on self-administration of medications.
3. Resident # 113 was admitted to the facility on [DATE], with most recent readmission 6/27/25. Her
diagnoses including fibromyalgia, anxiety, depression, myocardial infarction, and low back pain.
A review of the MDS quarterly assessment, with an assessment reference of 9/17/25, revealed that
resident #113 had a BIMS score of 11 out of 15, indicating she was moderately cognitively impaired.
On 9/22/25 at 3:26 PM, resident #133 was lying back in bed watching television. The resident's overbed
table contained personal items, including a 30 milliliter (ml) bottle of Systane Lubricant eye drops. The
resident stated she bought eye drops for her left eye because it gets scratchy.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105291
If continuation sheet
Page 2 of 4
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105291
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/25/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Life Care Center of Melbourne
606 E Sheridan Rd
Melbourne, FL 32901
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0554
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
On 9/22/25 at 3:30 PM, Registered Nurse (RN) B, the primary care nurse, entered the room. He
acknowledged the Systane lubricant eye drops, 30 milliliters on the residents table. Outside of the room a
review of the resident's physician orders with RN B revealed no orders for the Systane lubricant eye drops,
nor did the resident have a completed medication self-administration evaluation.
On 9/23/25 at 10:12 AM, the DON stated she spoke with resident #113, and the resident did not wish to
administer eye drops on her own. She explained a physician's order was obtained for the nurse to
administer the eye drop to the resident.
A review of the facility's policy and procedure for Self-Administration of Medication dated 9/16/24 revealed,
The facility will determine through an interdisciplinary assessment if the resident is able to either safely
administer medications that are requested from a central location (e.g.medication cart or medication room)
or the resident is able to safely store the medication in a secure location in room, and safely administer the
medication as prescribed.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105291
If continuation sheet
Page 3 of 4
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105291
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
09/25/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Life Care Center of Melbourne
606 E Sheridan Rd
Melbourne, FL 32901
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0867
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Set up an ongoing quality assessment and assurance group to review quality deficiencies and develop
corrective plans of action.
Based on interview, and record review, the facility failed to ensure the Quality Assessment & Assurance
(QAA) / Quality Assurance and Performance Improvement (QAPI) committee conducted performance
improvement activities to ensure prior improvement measures were sustained. Findings: Review of the
policy and procedure, Quality Assurance and Performance Improvement (QAPI) dated 12/20/19, revealed
the purpose of the facilities QAPI program was to promote excellence in quality care, quality of life resident
choice and person-centered care. The document indicated the facility conducted Performance Improvement
Plans (PIP) to examine and improve care or services in areas the facility identified as requiring
attention.The facility had deficiency cited at F554 related to resident self-administration of medication
during the previous recertification survey conducted 5/06/24 through 05/09/24. The same deficiency had
also been cited during the recertification survey conducted the year before, on 02/05/23 through
02/08/23.During the current survey, concerns were again found with resident self-administration of
medication, and the facility was found to be in noncompliance with F554. Insufficient auditing and oversight
by the facility to prevent the citation was identified to be a factor in the repeated deficiency.On 9/25/25 at
3:02 PM, the Administrator stated the QAPI committee met monthly and reviewed different areas such as
grievances, reportable events and deficiencies from previous surveys and complaints. She acknowledged
medications were found left at the bedside by staff during this survey and said they had been working on
the issue because they had been cited for this on the last survey. The Administrator produced an undated
Performance Improvement Plan (PIP) for medications with actions for nursing education related to
medications at the bedside and weekly random audits performed by the Unit Managers. The section titled
Evaluation date and Results indicated continue PIP, minimal progress, will need to reeducate. The section
was undated. The bottom of the PIP listed the action plan was completed on February 2025, to be followed
up monthly at QAPI. The Administrator verbalized they were working on the issue, and she confirmed it
continued to be a problem at the facility.
Event ID:
Facility ID:
105291
If continuation sheet
Page 4 of 4